Press releases

Report into online counterfeit drug trade highlights why local pharmacist remains safest source for patient prescriptions
01/07/2008
---
95.6% of online pharmacies operate illegally; nearly two thirds of online drugs found to be fake; problem moves beyond lifestyle drugs to cancer and serious cardiovascular diseases

Axway and Aegate announce alliance for patient safety and global supply chain security
10/06/2008
---
Alliance Offers Solution Framework for Global Serialization, Track & Trace and Pharmacy Drug Authentication

Aegate Endorses European Commission’s Industry Wide Drive To Address Counterfeit Drug Problem
12/05/2008
---
Commission's efforts to implement a standardised solution to counterfeit drug issue echoes findings from Aegate commissioned report, which calls for collective industry action

Twenty-three pharmaceutical companies join forces with Aegate in fight for patient safety
29/04/2008
---
At the launch today of a white paper on the use of mass serialisation for patient safety, developed in collaboration with leading industry analysts Frost and Sullivan, Aegate’s commitment to patient safety across Europe has been bolstered by the announcement that 23 leading pharmaceutical companies are now working alongside the company in its fight to assure the quality and safety of medicines that are dispensed to patients across Europe.

Frost & Sullivan report reveals lack of industry collaboration and decisive action as biggest threats to rising levels of counterfeit drugs.
29/04/2008
---
Mass serialisation identified as the key enabler in fight for patient safety

Aegate Stamps its Mark on Belgian Market
18/12/2007
---
Aegate strengthens position in Belgium following appointment of new General Manager and commencement of roll out with Corilus

Aegate joins forces with Domino on Drug Authentication
20/11/2007
---
Strategic collaboration provides extra layer of security to increase patient safety in the pharmaceutical industry

Aegate goes live in Greece
16/10/2007
---
Unique patient safety initiative launched for Greek pharmacists

Aegate strengthens European management team with senior appointment
27/09/2007
---
Aegate, the leading pharmaceutical authentication company is supporting its rapid European growth with the appointment of Graham Smith to its management team. Graham takes on the role of Aegate’s Business Development Vice President.

Aegate appoints Chief Operations Officer, Brian Thornley, GSK and EFPIA supply chain expert, to growing Aegate team
02/07/2007
---
Former Director of European Supply Chain for GlaxoSmithKline, Brian Thornley, has joined Aegate, the growing UK-based pharmaceutical authentication company active in the fight against counterfeit and substandard medicines, as Chief Operations Officer, effective immediately.

Next Stop: Greece
18/05/2007
---
Aegate announces it is entering the Greek market, offering a simple and effective solution to protect pharmaceutical brands against the risks of substandard or illegal medicines reaching patients

Medicines counterfeiting: a simple and effective solution exists to protect patients
14/05/2007
---
Aegate today told EU decision makers, participating in the first European Parliament symposium on medicines counterfeiting, that its patient safety and anti-counterfeit solution to protect patient...

Aegate unveils latest development in the fight against counterfeit drugs in developing countries
12/03/2007
---
Aegate Ltd today announced that it will unveil an important new technology in the fight against counterfeit medicines especially for the developing world.

OmegaSoft to commence pharmacy software integration with Aegate
12/12/2006
---
Aegate, the pharmaceutical authentication company, today announces that leading pharmacy software provider, OmegaSoft, will commence integration work with Aegate in 2007.

Professor Trevor Jones joins Aegate advisory board as drug authentication company looks to the developing world
30/10/2006
---
Aegate, the pharmaceutical authentication company, has today announced the appointment of Professor Trevor Jones CBE to its advisory board.

Pages: 1| 2 | 3